ABOUT THIS EPISODE
Today's episode looks at three research papers: a breast cancer surgery trial about whether women with early-stage lobular carcinoma still need lymph node biopsies, a commentary pushing back on a bone-drug study in postmenopausal Chinese women, and a screening tool analysis that quietly raises questions about who gets flagged for osteoporosis — and who doesn't.
Key Takeaways:
• The SOUND trial showed that many women with early-stage breast cancer can skip sentinel lymph node biopsy, but a new analysis questions whether those findings apply to a specific breast cancer type called invasive lobular carcinoma, which has a higher rate of lymph node involvement than other early-stage cancers.
• Eldecalcitol is a vitamin D analog used for postmenopausal osteoporosis in Japan and studied in Chinese women; a new commentary flags methodological concerns in the supporting study, including the lack of a control group and short follow-up — important caveats before anyone treats this as settled evidence.
• Osteoporosis screening tools developed and validated in one population often underperform in others; a Japanese men's study is a reminder that fracture risk calculators need to be tested — not assumed — in the groups they're used for.
• The gender gap in osteoporosis research runs in both directions: women are underrepresented in cardiovascular trials, but men are often underrepresented in bone health research, which means screening tools calibrated on women may miss at-risk men entirely.
• None of these papers are practice-changing on their own, but each one is the kind of evidence your doctor would weigh when making a specific call — the kind of thing worth knowing so you can ask better questions.
Sources & References:
• Axillary node upstaging in lobular breast cancer — can the SOUND trial results apply? (https://pubmed.ncbi.nlm.nih.gov/42802378/) - PubMed
• Commentary on eldecalcitol and calcium supplementation for postmenopausal osteoporosis in Chinese women (https://pubmed.ncbi.nlm.nih.gov/42802291/) - PubMed
• How well do osteoporosis screening tools work in elderly Japanese men? (https://pubmed.ncbi.nlm.nih.gov/42802288/) - PubMed
Listen with full show notes: https://hotflasher.com/episodes/2026-09-28-research-roundup
Have a menopause story to share? We'd love to hear it:
https://hotflasher.com/share
---
Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.
Key Takeaways:
• The SOUND trial showed that many women with early-stage breast cancer can skip sentinel lymph node biopsy, but a new analysis questions whether those findings apply to a specific breast cancer type called invasive lobular carcinoma, which has a higher rate of lymph node involvement than other early-stage cancers.
• Eldecalcitol is a vitamin D analog used for postmenopausal osteoporosis in Japan and studied in Chinese women; a new commentary flags methodological concerns in the supporting study, including the lack of a control group and short follow-up — important caveats before anyone treats this as settled evidence.
• Osteoporosis screening tools developed and validated in one population often underperform in others; a Japanese men's study is a reminder that fracture risk calculators need to be tested — not assumed — in the groups they're used for.
• The gender gap in osteoporosis research runs in both directions: women are underrepresented in cardiovascular trials, but men are often underrepresented in bone health research, which means screening tools calibrated on women may miss at-risk men entirely.
• None of these papers are practice-changing on their own, but each one is the kind of evidence your doctor would weigh when making a specific call — the kind of thing worth knowing so you can ask better questions.
Sources & References:
• Axillary node upstaging in lobular breast cancer — can the SOUND trial results apply? (https://pubmed.ncbi.nlm.nih.gov/42802378/) - PubMed
• Commentary on eldecalcitol and calcium supplementation for postmenopausal osteoporosis in Chinese women (https://pubmed.ncbi.nlm.nih.gov/42802291/) - PubMed
• How well do osteoporosis screening tools work in elderly Japanese men? (https://pubmed.ncbi.nlm.nih.gov/42802288/) - PubMed
Listen with full show notes: https://hotflasher.com/episodes/2026-09-28-research-roundup
Have a menopause story to share? We'd love to hear it:
https://hotflasher.com/share
---
Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.
English
United States
TRANSCRIPT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
OTHER EPISODES IN THIS PODCAST
This episode covers three things perimenopausal women deal with constantly but don't always get good answers on: gut changes, weight gain, and how to actually stick with strength training. Nykki pulls from a Harvard gastroenterologist's conversation about the gut-hormone connection, a Toronto Star …
Three new papers landed this week, and they're all quietly about cardiovascular risk in postmenopausal women — from how we read heart scans, to how dietary fat affects cholesterol and gut health, to why doctors still aren't getting enough training on menopause. This episode breaks down what the res…
This episode covers new research linking early menopause to higher cognitive risk, a 12-month study showing HRT reduces hand joint pain in perimenopausal women, and a USA Today look at whether pairing scientists with social media influencers is a real solution to menopause misinformation.
Key Take…
A large new study reveals that hormonal change during menopause isn't gradual — it drops sharply right at the final period, which may reshape how we think about timing treatment. This episode also covers a lifespan look at metabolic health and menopause, and a rare but important case report about w…
This episode covers a USA Today investigation into FDA warnings about UTIs turning fatal in menopausal women, a major global study finding women report more pain than men with the sharpest rise happening before age 55, and a controversy in Spain over an official menopause guide built almost entirel…
Disclaimer: The podcast and artwork embedded on this page are from Hot Flasher, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
EDIT
Thank you for helping to keep the podcast database up to date.
